D-Dimer, Quantitative

Overview

  • EPIC Code:
  • LAB313
  • Soft Test Code:
  • DIMQ2
Alternate Names
  • D-Dimer
  • Dimer
  • FDP
  • Fibrin Split Products
  • Fibrinogen Degradation Products
  • FSP
Clinical Significance

Quantitation of cross-linked fibrin degradation products in human plasma


Specimen Collection & Preparation

Specimen Requirements:

-OR-

2.7 mL Whole Blood in a Blue Top Tube - 3.2% Buffered Sodium Citrate
Minimum Volume:
1.8 mL Whole Blood from a Clear Blue Top Tube*

* This volume does not allow for repeat testing

Collection Instructions:

Specimens must be filled to minimum fill indicator line on the tube. BD Vacutainer Plus Citrate Tube Draw Volume Guide

If collected utilizing a "butterfly" collection device (also known as a Safety-Lok Collection Set), an extra discard Blue Tube must be drawn first to remove air from the line. If this is not done, the Blue Top Tube will not be filled properly due to the vacuum in tube and a redraw will be required

Note:

Collection of blood for coagulation testing through intravenous lines that have been previously flushed with heparin should be avoided, if possible.

If the blood must be drawn through an indwelling catheter, possible heparin contamination and specimen dilution should be considered. To decrease chance of heparin contamination:

  1. Flush the line with 5 mL of saline.
  2. Then the 5 mL of blood or 6-times the line volume (dead space volume of the catheter) should be drawn into a discard tube before filling the Blue Top Tube for coagulation testing.

For samples collected from a normal saline lock (capped off venous port), twice the dead space volume of the catheter and extension set should be discarded.


Processing Instructions:

Whole blood samples must be centrifuged in a centrifuged that has been validated for platelet poor plasma (PLT < 10,000/uL).


Rejection Criteria:

Clotted samples

Improperly filled tubes (under or overfilled)

Wrong anticoagulant (3.8% sodium citrate is NOT acceptable)

Patients with hematocrit (HCT) >55% (red cell volume is >1/2 tube volume)

Hemolyzed samples

Stability time exceeded

Frozen whole blood samples


Transport and Storage:
  • Ambient (18-24°C): 16 Hours

    Preferred.

  • Refrigerated (2-8°C): 24 Hours

    Samples should be sent refrigerated only if the sample will not reach the testing location within 16 Hours of collection.

Clinical Interpretation

Reference Range:

< 0.50 mg/L (FEU)


Test Comments:

In excluding deep vein thrombosis (DVT) and pulmonary (PE): In a non-high clinical probability population, using a cutoff of 0.5 mg/L FEU, a normal (<0.5 mg/L FEU) result excludes deep vein thrombosis (DVT) and pulmonary (PE) effectively. (Negative predictive value is 96-100% and 97.5-100% respectively)

In detecting DVT and PE: using a cutoff of 0.5 mg/L FEU, the sensitivity is 96-100% and 93.3-100% respectively and the specificity is 34.5% and 39.6% respectively.


Methodology:
  • Immunoassay (IA)
Clinical Significance

Quantitation of cross-linked fibrin degradation products in human plasma


Production Schedule

Sites Performed
  • Parkview DeKalb Hospital
  • Parkview Huntington Hospital
  • Parkview Kosciusko Hospital
  • Parkview LaGrange Hospital
  • Parkview Noble Hospital
  • Parkview Randallia Hospital
  • Parkview Regional Medical Center
  • Parkview Southwest
  • Parkview Wabash Hospital
  • Parkview Whitley Hospital
Days Performed
Sunday
Monday
Tuesday
Wednesday
Thursday
Friday
Saturday
Departments
  • Coagulation
Turn Around Time

Same day/1 to 2 days


Stat Eligible

Coding & Compliance

CDM

01495379


CPT Coding

85379